Insider · CIK 0001781021
Jian James Huang
officer
Files at ADNT (Adient plc). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | ADNT Adient plc | MOption exercise Ordinary Shares | +3,667 | $0.00 | $0 | 3,667 | Nov 18, 2025 |
| Nov 17, 2025 | ADNT Adient plc | DDisposition to issuer Ordinary Shares | -3,667 | $19.05 | $70k | 0 | Nov 18, 2025 |
| Nov 17, 2025 | ADNT Adient plc | MOption exercise Restricted Stock Unitsderivative | -3,667 | $0.00 | $0 | 0 | Nov 18, 2025 |
| Nov 13, 2025 | ADNT Adient plc | MOption exercise Ordinary Shares | +6,955 | $0.00 | $0 | 6,955 | Nov 17, 2025 |
| Nov 13, 2025 | ADNT Adient plc | DDisposition to issuer Ordinary Shares | -6,955 | $20.02 | $139k | 0 | Nov 17, 2025 |
| Nov 14, 2025 | ADNT Adient plc | MOption exercise Ordinary Shares | +60,512 | $0.00 | $0 | 60,512 | Nov 17, 2025 |
| Nov 14, 2025 | ADNT Adient plc | DDisposition to issuer Ordinary Shares | -60,512 | $20.02 | $1.2M | 0 | Nov 17, 2025 |
| Nov 16, 2025 | ADNT Adient plc | MOption exercise Ordinary Shares | +6,433 | $0.00 | $0 | 6,433 | Nov 17, 2025 |
| Nov 16, 2025 | ADNT Adient plc | DDisposition to issuer Ordinary Shares | -6,433 | $20.02 | $129k | 0 | Nov 17, 2025 |
| Nov 13, 2025 | ADNT Adient plc | AGrant or award Restricted Stock Unitsderivative | +47,281 | $0.00 | $0 | 47,281 | Nov 17, 2025 |
| Nov 13, 2025 | ADNT Adient plc | MOption exercise Performance Share Unitsderivative | -6,955 | $0.00 | $0 | 0 | Nov 17, 2025 |
| Nov 14, 2025 | ADNT Adient plc | MOption exercise Restricted Stock Unitsderivative | -60,512 | $0.00 | $0 | 0 | Nov 17, 2025 |
| Nov 16, 2025 | ADNT Adient plc | MOption exercise Restricted Stock Unitsderivative | -6,433 | $0.00 | $0 | 0 | Nov 17, 2025 |
| Nov 18, 2024 | ADNT Adient plc | MOption exercise Ordinary Shares | +3,017 | $0.00 | $0 | 3,017 | Nov 20, 2024 |
| Nov 18, 2024 | ADNT Adient plc | DDisposition to issuer Ordinary Shares | -3,017 | $19.75 | $60k | 0 | Nov 20, 2024 |
| Nov 18, 2024 | ADNT Adient plc | MOption exercise Restricted Stock Unitsderivative | -3,017 | $0.00 | $0 | 0 | Nov 20, 2024 |
| Nov 14, 2024 | ADNT Adient plc | MOption exercise Ordinary Shares | +7,188 | $0.00 | $0 | 7,188 | Nov 18, 2024 |
| Nov 14, 2024 | ADNT Adient plc | DDisposition to issuer Ordinary Shares | -7,188 | $20.40 | $147k | 0 | Nov 18, 2024 |
| Nov 16, 2024 | ADNT Adient plc | MOption exercise Ordinary Shares | +6,433 | $0.00 | $0 | 6,433 | Nov 18, 2024 |
| Nov 16, 2024 | ADNT Adient plc | DDisposition to issuer Ordinary Shares | -6,433 | $19.89 | $128k | 0 | Nov 18, 2024 |
| Nov 17, 2024 | ADNT Adient plc | MOption exercise Ordinary Shares | +3,558 | $0.00 | $0 | 3,558 | Nov 18, 2024 |
| Nov 17, 2024 | ADNT Adient plc | DDisposition to issuer Ordinary Shares | -3,558 | $19.89 | $71k | 0 | Nov 18, 2024 |
| Nov 14, 2024 | ADNT Adient plc | AGrant or award Restricted Stock Unitsderivative | +34,823 | $0.00 | $0 | 34,823 | Nov 18, 2024 |
| Nov 14, 2024 | ADNT Adient plc | AGrant or award Restricted Stock Unitsderivative | +98,039 | $0.00 | $0 | 98,039 | Nov 18, 2024 |
| Nov 14, 2024 | ADNT Adient plc | MOption exercise Performance Share Unitsderivative | -7,188 | $0.00 | $0 | 0 | Nov 18, 2024 |
| Nov 16, 2024 | ADNT Adient plc | MOption exercise Restricted Stock Unitsderivative | -6,433 | $0.00 | $0 | 0 | Nov 18, 2024 |
| Nov 17, 2024 | ADNT Adient plc | MOption exercise Restricted Stock Unitsderivative | -3,558 | $0.00 | $0 | 0 | Nov 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.